🇨🇦 Canada Health Canada
GLP-1 Peptides in Canada
GLP-1 receptor agonist peptides are the most-searched compounds in the research peptide space globally. Originally developed for type 2 diabetes, they are now widely studied for metabolic health and weight management.
4 Compounds in this category
COA Purity certified vendors only
Health Canada Regulatory body
Compounds in this category
GLP-1 Peptides
Phase 3 GLP-1
Retatrutide
Triple GLP-1/GIP/glucagon receptor agonist — next-generation metabolic research compound
Read research guide →
Approved GLP-1
Semaglutide
GLP-1 receptor agonist approved for type 2 diabetes and obesity management
Read research guide →
Approved GLP-1
Tirzepatide
Dual GLP-1/GIP receptor agonist approved for diabetes and obesity
Read research guide →
Approved GLP-1
Mounjaro
Brand name for tirzepatide — approved dual GIP/GLP-1 agonist for diabetes and weight management
Read research guide → Regulatory note Semaglutide and tirzepatide are prescription medicines in Canada. Retatrutide is in active clinical trials and is not approved for therapeutic use. For research purposes only.
This category in other markets